Allergan

Arcutis Appoints Interim Chief Financial Officer (CFO)

Retrieved on: 
Friday, August 18, 2023
IPO, Biotechnology, Unity, Allergan, Dermatitis, Unity Biotechnology, Psoriasis, Gilead, Dermatology, CFO, Growth, Kite Pharma, Therapy, Skin, Management, Pharmaceutical industry

WESTLAKE VILLAGE, Calif., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that John W. Smither, who served as Arcutis’ first Chief Financial Officer (CFO) from 2019 to 2021, has been appointed interim CFO effective August 31.

Key Points: 
  • WESTLAKE VILLAGE, Calif., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that John W. Smither, who served as Arcutis’ first Chief Financial Officer (CFO) from 2019 to 2021, has been appointed interim CFO effective August 31.
  • “We are delighted that John has agreed to step in as interim CFO.
  • He brings an incredible depth and breadth of both financial acumen and dermatology experience from his 25+-year career in the pharmaceutical industry, culminating in five successive CFO roles including his previous stint at Arcutis,” said Frank Watanabe, President and Chief Executive Officer of Arcutis.
  • “On behalf of our Board and team, I would like to thank Scott for his tremendous contributions to Arcutis.

Competitive Landscape in 2023 Conjunctivitis Treatment Market Features Key Players like Novartis, Allergan, and More - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 17, 2023
General Health, Pharmaceutical, Optical, Health, Alembic Pharmaceuticals, Subconjunctival bleeding, BMC, Allergy, Allergic conjunctivitis, Nature, Prevalence, Allergan, NCBI, COVID-19, Conjunctivitis, USD, Vernal keratoconjunctivitis, NicOx, Incidence, Eyelid, Novartis, Patient, Viral, Ageing, Genetically modified bacteria, Disease, Pharmaceutical industry, Palladium, Growth

The conjunctivitis treatment market is expected to register a CAGR of 4.1% over the forecast period.

Key Points: 
  • The conjunctivitis treatment market is expected to register a CAGR of 4.1% over the forecast period.
  • Thus the incidence of allergic conjunctivitis is expected to contribute to the market's growth during the forecast period.
  • The rising incidence of hemorrhagic conjunctivitis is expected to drive the demand for conjunctivitis treatment, thereby contributing to market growth.
  • The conjunctivitis treatment market is moderately consolidated in nature due to the presence of several companies operating globally as well as regionally.

Bausch + Lomb Solidifies Leadership Team

Retrieved on: 
Tuesday, August 1, 2023
Retail, Health, Other Retail, Specialty, General Health, Pharmaceutical, Optical, Boston Consulting Group, Partnership, Inovio Pharmaceuticals, Bausch & Lomb, PwC, Allergan, Bausch, Waterhouse, Johnson & Johnson Vision, Privacy, Merck, Digital, Merrill (company), NYSE, Management, Saunders

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced changes to its executive leadership team including the creation of two new roles.

Key Points: 
  • Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced changes to its executive leadership team including the creation of two new roles.
  • The moves build on a reshuffling announced in early June after Chairman and CEO Brent Saunders, who previously served as CEO from 2010 to 2013, rejoined Bausch + Lomb.
  • “Seizing the opportunity in front of us means acting swiftly, which is why I’ve been so focused on establishing a refreshed leadership team,” said Saunders.
  • Gevgilili is currently chief human resources officer at INOVIO Pharmaceuticals and previously held human resources leadership roles at Allergan, Merck and Merrill Lynch.

Newsweek Names Dr. Brian K. Reedy of Berks Plastic Surgery One of America's Best Plastic Surgeons for 2023

Retrieved on: 
Tuesday, August 1, 2023
Surgeon, Face, Allergan, Reading, Breast, Breast augmentation, Dermatology, Patient, Health, Dentistry, Nursing, Newsweek

WYOMISSING, Pa., Aug. 1, 2023 /PRNewswire/ -- Dr. Brian K. Reedy of Berks Plastic Surgery has been recognized as one of the nation's top plastic surgeons by Newsweek magazine for the third consecutive year. In addition to liposuction, Dr. Reedy has also been awarded for breast augmentation in previous years. The "America's Best Plastic Surgeon 2023" rankings were determined by evaluations from fellow plastic surgeons and other medical experts in the field and awarded based on the number of recommendations, additional quality assessments, and proof of relevant certifications.

Key Points: 
  • The highly sought-after Berks County, PA plastic surgeon was recognized as one of the top liposuction surgeons in the country
    WYOMISSING, Pa., Aug. 1, 2023 /PRNewswire/ -- Dr. Brian K. Reedy of Berks Plastic Surgery has been recognized as one of the nation's top plastic surgeons by Newsweek magazine for the third consecutive year.
  • In addition to liposuction, Dr. Reedy has also been awarded for breast augmentation in previous years.
  • The "America's Best Plastic Surgeon 2023" rankings were determined by evaluations from fellow plastic surgeons and other medical experts in the field and awarded based on the number of recommendations, additional quality assessments, and proof of relevant certifications.
  • "It's an honor to have my skills recognized by my peers and Newsweek," said Dr. Reedy.

Medical Aesthetics Market size worth $ 27.55 Billion, Globally, by 2028 at 10.6% CAGR: Verified Market Research®

Retrieved on: 
Monday, July 24, 2023
Hair removal, Surgeon, Medicine, Face, Bank statement, Research, USD, Syneron Medical, Dermatology, SWOT, Allergan, Physician, Geography, Knowledge, Growth, Johnson & Johnson, Skin, Pharmaceutical industry, Dentistry, Renewable energy, Risk management

JERSEY CITY, N.J, July 24, 2023 /PRNewswire/ -- The Global Medical Aesthetics Market is projected to grow at a CAGR of 10.6% from 2021 to 2028, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 11.41 Billion in 2020 and is expected to reach USD 27.55 Billion by the end of the forecast period.

Key Points: 
  • The "Global Medical Aesthetics Market Size By Product, By End User, By Geographic Scope And Forecast" report has been published by Verified Market Research®.
  • The report provides an in-depth analysis of the global Medical Aesthetics Market, including its growth prospects, market trends, and market challenges.
  • For more information, financial statements, product benchmarking, and SWOT analysis, on the Global Medical Aesthetics Market, please purchase Medical Aesthetics Market report at Verified Market Research .
  • Based on the research, Verified Market Research® has segmented the global Medical Aesthetics Market into Product, End User, And Geography.

Medical Aesthetics Market size worth $ 27.55 Billion, Globally, by 2028 at 10.6% CAGR: Verified Market Research®

Retrieved on: 
Monday, July 24, 2023
Hair removal, Surgeon, Medicine, Face, Bank statement, Research, USD, Syneron Medical, Dermatology, SWOT, Allergan, Physician, Geography, Knowledge, Growth, Johnson & Johnson, Skin, Pharmaceutical industry, Dentistry, Renewable energy, Risk management

JERSEY CITY, N.J, July 24, 2023 /PRNewswire/ -- The Global Medical Aesthetics Market is projected to grow at a CAGR of 10.6% from 2021 to 2028, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 11.41 Billion in 2020 and is expected to reach USD 27.55 Billion by the end of the forecast period.

Key Points: 
  • The "Global Medical Aesthetics Market Size By Product, By End User, By Geographic Scope And Forecast" report has been published by Verified Market Research®.
  • The report provides an in-depth analysis of the global Medical Aesthetics Market, including its growth prospects, market trends, and market challenges.
  • For more information, financial statements, product benchmarking, and SWOT analysis, on the Global Medical Aesthetics Market, please purchase Medical Aesthetics Market report at Verified Market Research .
  • Based on the research, Verified Market Research® has segmented the global Medical Aesthetics Market into Product, End User, And Geography.

Amarin Appoints Patrick Holt as President and Chief Executive Officer

Retrieved on: 
Tuesday, July 18, 2023
Vaccine, Interim, Allergan, Sale, Amarin, Professional corporation, Patient, Physician, Management, Cordis, Merck

DUBLIN, Ireland and BRIDGEWATER, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that the Company’s Board of Directors has appointed Patrick Holt as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately.

Key Points: 
  • DUBLIN, Ireland and BRIDGEWATER, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that the Company’s Board of Directors has appointed Patrick Holt as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately.
  • Aaron Berg, who served as Interim President and CEO since April 2023, will remain with the Company in a senior leadership role.
  • Mr. Holt brings more than 25 years of leadership in the life sciences industry and significant international operating experience.
  • Mr. Holt previously held a variety of senior executive positions across biopharmaceuticals and vaccines at Allergan and Merck.

Adicet Announces Appointment of Katie Peng to the Board of Directors

Retrieved on: 
Tuesday, July 11, 2023
Biotechnology, Pharmaceutical, Health, Oncology, SMA, Indiana University, University, Senior, Spinal muscular atrophy, ACET, Berkeley, Marketing, Bio, Amgen, Roche, Kelley School of Business, Allergan, Cancer, Multimedia, Medicine, Research, Multiple sclerosis, CAR, Emicizumab, Therapy, Neurology, Pharmaceutical industry, Genentech

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced the appointment of Katie Peng to its Board of Directors.

Key Points: 
  • Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced the appointment of Katie Peng to its Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20230711946213/en/
    “We are delighted to welcome Katie to our Board of Directors,” said Chen Schor, President and Chief Executive Officer of Adicet Bio.
  • Before joining Roche, Ms. Peng held several commercial roles at Amgen Inc. and began her career as a research scientist at Allergan plc.
  • She also serves as a board member for California Life Sciences.

'Radical Reinvention' - Fearless Realignment in a Post-Covid Complex World

Retrieved on: 
Monday, July 10, 2023
Constellation, Survivor, Uncertainty, Lippe (district), Constellation Brands, Beauty, Painting, Network, Armageddon, Marines, Domestic violence, Policy, COVID-19, Keurig, LVMH, Leg, Iraq, Amazon, Harper, Clairol, Procter & Gamble, Walmart, Museum, Intel, Terror, Reading, Charles Lahr, IKEA, Bazaar, Health, Harper's Bazaar, Wells Fargo, Success, PR, Reset, Management, Book, Nordstrom, Galderma, Allergan, Vogue, Pfizer

NEW YORK, July 10, 2023 /PRNewswire/ -- (Lippe Taylor Group)—Follow the turtle on wheels! …That is, the one on the eye-popping cover of Radical Reinvention: Reimagine, Reset, Reinvent in a Disruptive World, the new book by New York City-based editorial and PR mogul, Maureen Lippe. 

Key Points: 
  • …That is, the one on the eye-popping cover of Radical Reinvention: Reimagine, Reset, Reinvent in a Disruptive World, the new book by New York City-based editorial and PR mogul, Maureen Lippe.
  • Company reinventions such as Lippe Taylor Group, LVMH (Louis Vuitton Moët Hennessey), and Wells Fargo command a large section of the book, with sterling tips by brand transformation experts.
  • She was then an on-air correspondent on Live with Regis and Kathie Lee doing weekly makeover segments.
  • After reading this book, you will learn how to be more resilient and not retract for long.

Zymeworks Appoints New Director

Retrieved on: 
Thursday, June 29, 2023
Lundbeck Seattle Biopharmaceuticals, Lundbeck, Culture, Allergan, Eptinezumab, Eli Lilly, Organization, Acquisition, Patient, Cancer, Eli Lilly and Company, Therapy, Management, Zymeworks, Indiana University

Mr. Campoy brings extensive strategic and financial leadership experience in the pharmaceutical and biotechnology sectors to the Zymeworks board of directors.

Key Points: 
  • Mr. Campoy brings extensive strategic and financial leadership experience in the pharmaceutical and biotechnology sectors to the Zymeworks board of directors.
  • Mr. Campoy succeeds Dr. Natalie Sacks, who will step down effective as of June 30 after a successful 6-year tenure as board director of Zymeworks.
  • “The entire Zymeworks’ board of directors and employees are sincerely grateful to Dr. Sacks for her dedicated service to Zymeworks.
  • Egon Zehnder, a global leadership advisory firm, was actively engaged with Zymeworks in an advisory capacity and assisted in the recruitment of Mr. Campoy to the Zymeworks’ board of directors.